Geneseeq raised $114m in a China Reform-led series D funding round.

Geneseeq, a manufacturer of biotechnology products, raised $114m in a China Reform-led series D funding round. China-based biomedical venture capital firm Lilly Asia Ventures, SoftBank China Venture Capital, the China-focused investment arm of Japanese conglomerate SoftBank Group and other investors also participated in the new round.